Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection

Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection

IntroductionThis study compares the immune responses of healthy individuals, with or without prior SARS-CoV-2 infection, following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca).MethodsA total of 134 volunteers were analyzed: 71 recipients of Comirnaty (36 with prior infection) and...

Full description

Saved in:
Bibliographic Details
Main Authors: Zdzisława Kondera-Anasz, Emilia Justyna Morawiec, Roksana Duszkiewicz, Filip Hajdrowski, Andrzej Wiczkowski
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Comirnaty BNT162b2
Vaxzevria ChAdOx1-S
COVID-19 vaccines
anti-SARS-CoV-2 IgG
interferon-gamma
immune response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1612288/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items